Evidence map›Paper›PMID 41035625›Full record

ArticleFrontiers in health services2025

Health care benefits package design to improve outcomes in resource-constrained settings: suggestions for Tajikistan.

Jens Wilkens, Alona Goroshko, Malika Khakimova, Farrukh Egamov, Triin Habicht, Ilker Dastan

Abstract read
In one paragraph

Article in Frontiers in health services, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jens WilkensDepartment of Clinical Sciences, Lund University, Malmö, Sweden.
Alona GoroshkoWHO Country Office, Dushanbe, Tajikistan.
Malika KhakimovaWHO Country Office, Dushanbe, Tajikistan.
Farrukh EgamovWHO Country Office, Dushanbe, Tajikistan.
Triin HabichtWorld Health Organization Barcelona Office for Health Systems Financing, Barcelona, Spain.
Ilker DastanWHO Country Office, Dushanbe, Tajikistan.

Funding

World Health Organization 001
6 · The paper itself

Abstract

The Tajik health system is characterized by improving health outcomes over the last 20 years, but also major inefficiencies in health care delivery and large difficulties for people to access affordable essential health care. The benefits package (BP) is a key tool for prioritizing state budget allocations toward health interventions that most effectively enhance health system performance. This article suggests directions for a new BP, which is envisioned in the currently ongoing reforms. Using a universal health coverage framework, the article examines how the public budget is prioritized in the current BP and investigates the main performance challenges addressed in the government's ongoing health reform efforts from a BP perspective. Criteria for a new BP are outlined, along with suggestions for their application. The article explains how BP design can improve health system performance in a budget-constrained setting by focusing on primary health care interventions and eliminating user fees for child and maternal health services, without requiring additional budget resources. The main strength of the current BP is the provision of free family doctor and nurse consultations for all. However, its narrow scope and high user fees for essential interventions hinder both the effective management of highly prevalent chronic non-communicable diseases and the efficient use of public resources. The user fee exemptions for vulnerable population groups are neither rational in design nor possible to evaluate due to the absence of data.

Indexed as

benefits packagebudget resourceseffective primary health careprioritizationuniversal health coverage

Identifiers

PMID41035625
PMCPMC12482916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.